News

PEN Q1 Earnings Call: U.S. Thrombectomy Drives Outperformance as International Headwinds Persist
Medical device company Penumbra (NYSE:PEN) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 16.3% year on ...